Variation in parathyroid hormone immunoassay results—a critical governance issue in the management of chronic kidney disease

por Sturgeon, Catharine M., Sprague, Stuart M., Metcalfe, Wendy
Publicado 2011

Taking a new biomarker into routine use – A perspective from the routine clinical biochemistry laboratory

por Sturgeon, Catharine, Hill, Robert, Hortin, Glen L, Thompson, Douglas
Publicado 2010

Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection

por Bird, Thomas G., Dimitropoulou, Polyxeni, Turner, Rebecca M., Jenks, Sara J., Cusack, Pearce, Hey, Shiying, Blunsum, Andrew, Kelly, Sarah, Sturgeon, Catharine, Hayes, Peter C., Bird, Sheila M.
Publicado 2016

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers

por Sölétormos, György, Duffy, Michael J., Othman Abu Hassan, Suher, Verheijen, René H.M., Tholander, Bengt, Bast, Robert C., Gaarenstroom, Katja N., Sturgeon, Catharine M., Bonfrer, Johannes M., Petersen, Per Hyltoft, Troonen, Hugo, CarloTorre, Gian, Kanty Kulpa, Jan, Tuxen, Malgorzata K., Molina, Raphael
Publicado 2016